Allergan confirms fatality not caused by Botox cosmetic

Allergan, Inc. responds to Public Citizen’s allegation regarding a fatality following BOTOX(R) Cosmetic Treatment. – In response to public reports suggesting a causal link between a BOTOX(R) Cosmetic treatment in 2003 and a fatality, Allergan, Inc. (NYSE:AGN) provided further assurance to patients and the public about BOTOX(R) Cosmetic and BOTOX(R) (Botulinum Toxin Type A).

Stricter warnings for botox, myobloc botulinum injections

Botox and a similar injection Myobloc should come with stronger warnings following reports of 16 deaths after the botulinum toxin spread inside the body, a U.S. consumer group Public Citizen said.
– The Food and Drug Administration (FDA) should immediately increase its warnings and directly warn patients and doctors about the use of botulinum toxin ? available as Botox and Myobloc ? because of serious adverse reactions, including deaths, linked to the drug, Public Citizen said in a petition filed with the FDA.

Integrated health strategies can save children’s lives, says UNICEF

The State of the World?s Children 2008: Child Survival – The report provides information on a strategic framework developed by UNICEF, WHO, and the World Bank ? at the invitation of the African Union ? to help African countries and others reduce the toll of maternal and child deaths.
– Strategies that can help reduce the number of children who die before their fifth birthday were highlighted today, at the launch of UNICEF’s flagship report – The State of the World’s Children 2008: Child Survival ? in Geneva.

Prodesse’s ProFlu+ Test for Respiratory Viruses receives FDA clearance

Prodesse’s ProFlu+ Test for Respiratory Viruses receives FDA clearance for Marketing Real-Time Test, detects four viruses, including influenza; results available in about 3 hours. – Prodesse, Inc., the leader in multiplex real-time PCR for infectious disease, announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market its ProFlu+? Assay.

New test to detect and identify 12 respiratory viruses

The U.S. Food and Drug Administration cleared for marketing a test – xTAG Respiratory Viral Panel, manufactured by Luminex Molecular Diagnostics, that simultaneously detects and identifies 12 specific respiratory viruses. – The U.S. Food and Drug Administration has approved a new diagnostic test that detects 12 respiratory viruses, including strains of flu that have triggered epidemics.

Quick Test For Drug-Resistant Staph Infections MRSA

The U.S. Food and Drug Administration (FDA) approved the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus). – The U.S. Food and Drug Administration (FDA) announced it has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus), which can cause potentially deadly infections.